Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dictyostelium | 16 | 2017 | 114 | 2.180 |
Why?
|
| Computational Biology | 12 | 2016 | 794 | 2.050 |
Why?
|
| Gene Expression Profiling | 16 | 2017 | 1680 | 1.710 |
Why?
|
| User-Computer Interface | 7 | 2017 | 151 | 1.630 |
Why?
|
| Software | 10 | 2014 | 672 | 1.330 |
Why?
|
| Artificial Intelligence | 6 | 2013 | 231 | 0.990 |
Why?
|
| Database Management Systems | 4 | 2013 | 30 | 0.750 |
Why?
|
| Algorithms | 11 | 2016 | 1578 | 0.710 |
Why?
|
| Databases, Genetic | 4 | 2014 | 469 | 0.680 |
Why?
|
| Computer Graphics | 4 | 2014 | 37 | 0.630 |
Why?
|
| Models, Genetic | 6 | 2014 | 748 | 0.570 |
Why?
|
| Internet | 5 | 2017 | 369 | 0.540 |
Why?
|
| Semantics | 1 | 2016 | 18 | 0.540 |
Why?
|
| Data Compression | 1 | 2016 | 12 | 0.540 |
Why?
|
| Sequence Analysis, RNA | 4 | 2017 | 376 | 0.510 |
Why?
|
| Drug Interactions | 1 | 2016 | 252 | 0.490 |
Why?
|
| Databases, Factual | 3 | 2013 | 1163 | 0.480 |
Why?
|
| Disease | 1 | 2016 | 129 | 0.480 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2010 | 999 | 0.480 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2014 | 2580 | 0.450 |
Why?
|
| Models, Statistical | 2 | 2014 | 448 | 0.440 |
Why?
|
| Multigene Family | 3 | 2017 | 299 | 0.420 |
Why?
|
| Information Storage and Retrieval | 3 | 2007 | 60 | 0.420 |
Why?
|
| Genomics | 6 | 2010 | 1472 | 0.410 |
Why?
|
| Data Interpretation, Statistical | 2 | 2010 | 203 | 0.390 |
Why?
|
| Femoral Neck Fractures | 1 | 2010 | 7 | 0.360 |
Why?
|
| Hip Joint | 1 | 2010 | 37 | 0.350 |
Why?
|
| Cell Differentiation | 4 | 2013 | 1935 | 0.350 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 172 | 0.350 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2010 | 80 | 0.320 |
Why?
|
| Genome-Wide Association Study | 3 | 2014 | 1632 | 0.300 |
Why?
|
| Cluster Analysis | 3 | 2017 | 387 | 0.300 |
Why?
|
| Protozoan Proteins | 4 | 2013 | 109 | 0.290 |
Why?
|
| Data Mining | 3 | 2013 | 54 | 0.290 |
Why?
|
| Saccharomyces cerevisiae | 4 | 2014 | 423 | 0.290 |
Why?
|
| Databases, Protein | 1 | 2007 | 55 | 0.290 |
Why?
|
| Models, Biological | 2 | 2016 | 1438 | 0.290 |
Why?
|
| Biomedical Engineering | 1 | 2007 | 30 | 0.280 |
Why?
|
| Clinical Medicine | 1 | 2006 | 21 | 0.270 |
Why?
|
| Chromosome Mapping | 2 | 2011 | 1067 | 0.270 |
Why?
|
| Statistics as Topic | 1 | 2006 | 244 | 0.260 |
Why?
|
| Proteome | 1 | 2007 | 233 | 0.250 |
Why?
|
| Guidelines as Topic | 1 | 2006 | 194 | 0.250 |
Why?
|
| Computer Simulation | 4 | 2014 | 616 | 0.240 |
Why?
|
| Programming Languages | 1 | 2004 | 17 | 0.240 |
Why?
|
| Gene Regulatory Networks | 4 | 2017 | 354 | 0.230 |
Why?
|
| Genes | 1 | 2005 | 444 | 0.230 |
Why?
|
| Gene Expression Regulation | 2 | 2003 | 2541 | 0.230 |
Why?
|
| Precision Medicine | 2 | 2018 | 310 | 0.230 |
Why?
|
| Expert Systems | 1 | 2003 | 15 | 0.220 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 676 | 0.210 |
Why?
|
| RNA, Messenger | 3 | 2015 | 2833 | 0.200 |
Why?
|
| Oogenesis | 2 | 2012 | 52 | 0.200 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2012 | 1007 | 0.190 |
Why?
|
| Gene Expression | 3 | 2011 | 1592 | 0.190 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2017 | 864 | 0.190 |
Why?
|
| DNA Mutational Analysis | 1 | 2003 | 796 | 0.180 |
Why?
|
| Transcriptome | 2 | 2017 | 909 | 0.170 |
Why?
|
| Oocytes | 2 | 2012 | 291 | 0.170 |
Why?
|
| Signal Transduction | 3 | 2011 | 4524 | 0.170 |
Why?
|
| Biomarkers, Tumor | 1 | 2007 | 1431 | 0.170 |
Why?
|
| Biomedical Research | 3 | 2008 | 510 | 0.150 |
Why?
|
| Sequence Analysis, DNA | 2 | 2009 | 1760 | 0.150 |
Why?
|
| Pyrophosphatases | 1 | 2017 | 20 | 0.150 |
Why?
|
| DNA, Complementary | 3 | 2013 | 465 | 0.140 |
Why?
|
| Bayes Theorem | 2 | 2016 | 264 | 0.140 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2017 | 240 | 0.140 |
Why?
|
| Pattern Recognition, Automated | 2 | 2008 | 46 | 0.140 |
Why?
|
| Gene Ontology | 1 | 2016 | 48 | 0.130 |
Why?
|
| Databases, Pharmaceutical | 1 | 2016 | 3 | 0.130 |
Why?
|
| Neoplasms | 2 | 2008 | 2749 | 0.130 |
Why?
|
| Classification | 1 | 2016 | 18 | 0.130 |
Why?
|
| Systems Integration | 1 | 2016 | 27 | 0.130 |
Why?
|
| Likelihood Functions | 1 | 2016 | 107 | 0.130 |
Why?
|
| Mutation | 5 | 2013 | 5793 | 0.130 |
Why?
|
| Drug Therapy | 1 | 2016 | 87 | 0.130 |
Why?
|
| Spores, Protozoan | 2 | 2013 | 18 | 0.120 |
Why?
|
| Probability | 1 | 2016 | 318 | 0.120 |
Why?
|
| Genome, Protozoan | 2 | 2013 | 26 | 0.120 |
Why?
|
| Epistasis, Genetic | 2 | 2005 | 83 | 0.120 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2011 | 160 | 0.120 |
Why?
|
| DNA Primers | 2 | 2013 | 669 | 0.120 |
Why?
|
| DNA, Fungal | 1 | 2014 | 75 | 0.110 |
Why?
|
| ROC Curve | 1 | 2016 | 551 | 0.110 |
Why?
|
| Animals | 12 | 2012 | 33911 | 0.110 |
Why?
|
| Wine | 1 | 2013 | 15 | 0.110 |
Why?
|
| Microsatellite Repeats | 1 | 2014 | 218 | 0.110 |
Why?
|
| Immunoprecipitation | 2 | 2011 | 198 | 0.110 |
Why?
|
| Machine Learning | 1 | 2016 | 213 | 0.110 |
Why?
|
| Base Sequence | 3 | 2013 | 3118 | 0.110 |
Why?
|
| RNA, Protozoan | 1 | 2013 | 10 | 0.110 |
Why?
|
| Gram-Positive Bacteria | 1 | 2013 | 46 | 0.110 |
Why?
|
| Gram-Negative Bacteria | 1 | 2013 | 67 | 0.110 |
Why?
|
| Molecular Sequence Data | 3 | 2013 | 3888 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2013 | 191 | 0.100 |
Why?
|
| Molecular Sequence Annotation | 1 | 2013 | 144 | 0.100 |
Why?
|
| Biological Evolution | 2 | 2010 | 221 | 0.100 |
Why?
|
| Gene Library | 1 | 2013 | 220 | 0.100 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2012 | 42 | 0.100 |
Why?
|
| Humans | 14 | 2018 | 122517 | 0.100 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2011 | 110 | 0.090 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2010 | 25 | 0.090 |
Why?
|
| Nucleotides | 1 | 2010 | 92 | 0.090 |
Why?
|
| False Positive Reactions | 1 | 2010 | 143 | 0.080 |
Why?
|
| Biomechanical Phenomena | 1 | 2010 | 237 | 0.080 |
Why?
|
| Conserved Sequence | 1 | 2010 | 293 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 1598 | 0.080 |
Why?
|
| Transcription, Genetic | 3 | 2013 | 1703 | 0.080 |
Why?
|
| Systems Biology | 1 | 2008 | 60 | 0.080 |
Why?
|
| Genome | 1 | 2011 | 471 | 0.080 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2008 | 19 | 0.080 |
Why?
|
| Alternative Splicing | 1 | 2010 | 346 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2014 | 1476 | 0.070 |
Why?
|
| RNA | 1 | 2011 | 577 | 0.070 |
Why?
|
| Crush Syndrome | 1 | 2007 | 4 | 0.070 |
Why?
|
| Social Behavior | 1 | 2009 | 206 | 0.070 |
Why?
|
| Rescue Work | 1 | 2007 | 9 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 570 | 0.070 |
Why?
|
| Knowledge Bases | 1 | 2006 | 36 | 0.070 |
Why?
|
| Stem Cells | 1 | 2011 | 713 | 0.070 |
Why?
|
| Myocytes, Cardiac | 1 | 2011 | 618 | 0.070 |
Why?
|
| Triage | 1 | 2007 | 140 | 0.060 |
Why?
|
| Biometry | 1 | 2007 | 129 | 0.060 |
Why?
|
| Disasters | 1 | 2007 | 99 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 804 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 931 | 0.060 |
Why?
|
| Rats | 1 | 2011 | 3659 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2011 | 836 | 0.060 |
Why?
|
| Knowledge | 1 | 2003 | 45 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2007 | 1402 | 0.050 |
Why?
|
| Phenotype | 4 | 2014 | 4220 | 0.050 |
Why?
|
| Research Design | 1 | 2006 | 646 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2003 | 231 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2004 | 274 | 0.050 |
Why?
|
| Larva | 1 | 2003 | 247 | 0.050 |
Why?
|
| Research | 1 | 2003 | 260 | 0.050 |
Why?
|
| Genes, Protozoan | 2 | 2013 | 25 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2003 | 223 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2009 | 1529 | 0.050 |
Why?
|
| Mice | 3 | 2012 | 17646 | 0.040 |
Why?
|
| Ultraviolet Rays | 2 | 2011 | 205 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 6317 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2006 | 993 | 0.040 |
Why?
|
| A549 Cells | 1 | 2017 | 45 | 0.040 |
Why?
|
| DNA | 1 | 2003 | 1608 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2007 | 3307 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2017 | 284 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2017 | 222 | 0.040 |
Why?
|
| Protein Binding | 2 | 2011 | 1738 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 261 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 497 | 0.030 |
Why?
|
| Phylogeny | 1 | 2017 | 685 | 0.030 |
Why?
|
| United States | 2 | 2008 | 10499 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2015 | 247 | 0.030 |
Why?
|
| Morphogenesis | 1 | 2015 | 213 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 140 | 0.030 |
Why?
|
| Middle Aged | 2 | 2010 | 25651 | 0.030 |
Why?
|
| Aged | 1 | 2010 | 18836 | 0.030 |
Why?
|
| Genes, Bacterial | 1 | 2013 | 208 | 0.030 |
Why?
|
| Cell Line | 1 | 2017 | 2787 | 0.030 |
Why?
|
| Blastomeres | 1 | 2012 | 8 | 0.030 |
Why?
|
| Female | 4 | 2012 | 65064 | 0.020 |
Why?
|
| Sarcoglycans | 1 | 2011 | 7 | 0.020 |
Why?
|
| Muscle Development | 1 | 2011 | 71 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 252 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2011 | 231 | 0.020 |
Why?
|
| Uridine | 1 | 2010 | 34 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 3299 | 0.020 |
Why?
|
| Plasmids | 1 | 2011 | 516 | 0.020 |
Why?
|
| Databases, Bibliographic | 1 | 2010 | 20 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1885 | 0.020 |
Why?
|
| Adult | 1 | 2010 | 28800 | 0.020 |
Why?
|
| RNA Precursors | 1 | 2010 | 67 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2011 | 223 | 0.020 |
Why?
|
| Alleles | 1 | 2014 | 1596 | 0.020 |
Why?
|
| Natural Language Processing | 1 | 2010 | 63 | 0.020 |
Why?
|
| Species Specificity | 1 | 2010 | 552 | 0.020 |
Why?
|
| Regeneration | 1 | 2011 | 205 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 701 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2010 | 808 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 1302 | 0.020 |
Why?
|
| Education | 1 | 2008 | 105 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 2534 | 0.020 |
Why?
|
| Europe | 1 | 2008 | 370 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 5983 | 0.020 |
Why?
|
| Male | 2 | 2010 | 59687 | 0.020 |
Why?
|
| Pulse | 1 | 2007 | 30 | 0.020 |
Why?
|
| Urine | 1 | 2007 | 88 | 0.020 |
Why?
|
| Tachycardia | 1 | 2007 | 67 | 0.020 |
Why?
|
| Japan | 1 | 2007 | 134 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 751 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2007 | 245 | 0.020 |
Why?
|
| DNA, Protozoan | 1 | 2006 | 29 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 2006 | 190 | 0.020 |
Why?
|
| Retroelements | 1 | 2006 | 41 | 0.020 |
Why?
|
| Hyperkalemia | 1 | 2007 | 65 | 0.020 |
Why?
|
| Chromosomes | 1 | 2006 | 199 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2010 | 479 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2007 | 995 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 1354 | 0.020 |
Why?
|
| CpG Islands | 1 | 2006 | 321 | 0.010 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2006 | 128 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2005 | 151 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 6186 | 0.010 |
Why?
|
| Logistic Models | 1 | 2007 | 1771 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 2086 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2010 | 2588 | 0.010 |
Why?
|
| Biomarkers | 1 | 2008 | 2940 | 0.010 |
Why?
|
| Prognosis | 1 | 2007 | 4488 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2007 | 4661 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2007 | 15906 | 0.010 |
Why?
|